Compare TLYS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLYS | TELA |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.0M | 51.2M |
| IPO Year | 2012 | 2019 |
| Metric | TLYS | TELA |
|---|---|---|
| Price | $1.80 | $1.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.25 | ★ $3.31 |
| AVG Volume (30 Days) | 338.5K | ★ 351.8K |
| Earning Date | 12-03-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $545,742,000.00 | $77,055,000.00 |
| Revenue This Year | N/A | $18.39 |
| Revenue Next Year | $1.18 | $15.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.24 |
| 52 Week Low | $0.57 | $0.86 |
| 52 Week High | $4.75 | $3.12 |
| Indicator | TLYS | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 69.08 | 44.69 |
| Support Level | $1.26 | $1.09 |
| Resistance Level | $1.90 | $1.28 |
| Average True Range (ATR) | 0.16 | 0.11 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 86.84 | 53.57 |
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.